L
Laura McNicholas
Researcher at Veterans Health Administration
Publications - 16
Citations - 1481
Laura McNicholas is an academic researcher from Veterans Health Administration. The author has contributed to research in topics: Buprenorphine & Methadone. The author has an hindex of 10, co-authored 16 publications receiving 1377 citations. Previous affiliations of Laura McNicholas include University of Pennsylvania & United States Department of Veterans Affairs.
Papers
More filters
Journal ArticleDOI
Office-Based Treatment of Opiate Addiction with a Sublingual-Tablet Formulation of Buprenorphine and Naloxone
Paul J. Fudala,T. Peter Bridge,Susan Herbert,William O. Williford,C. Nora Chiang,Karen Jones,Joseph F. Collins,Dennis W. Raisch,Paul Casadonte,R. Jeffrey Goldsmith,Walter Ling,Usha Malkerneker,Laura McNicholas,John A. Renner,Susan M. Stine,Donald J. Tusel +15 more
TL;DR: Buprenorphines and naloxone in combination and buprenorphine alone are safe and reduce the use of opiates and the craving for opiates among opiate-addicted persons who receive these medications in an office-based setting.
Journal ArticleDOI
Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial.
Walter Ling,Charles Charuvastra,Joseph Collins,Steve Batki,Lawrence S. Brown,Prudencia C. Kintaudi,Donald R. Wesson,Laura McNicholas,Donald J. Tusel,Usha Malkerneker,John A. Renner,Erick Santos,Paul Casadonte,Carol Fye,Susan M. Stine,Richard I. H. Wang,Doralie Segal +16 more
TL;DR: It is suggested that an adequate dose of buprenorphine will be a useful addition to pharmacotherapy and safety outcome measures provided by clinical monitoring and by analysis of the reported adverse events.
Journal ArticleDOI
Extended vs Short-term Buprenorphine-Naloxone for Treatment of Opioid-Addicted Youth: A Randomized Trial
George E. Woody,Sabrina Poole,Geetha Subramaniam,Karen L. Dugosh,Michael P. Bogenschutz,Patrick J. Abbott,Ashwin A. Patkar,Mark Publicker,Karen McCain,Jennifer Sharpe Potter,Robert F. Forman,Victoria L. Vetter,Laura McNicholas,Jack Blaine,Kevin G. Lynch,Paul J. Fudala +15 more
TL;DR: Continuing treatment with buprenorphine-naloxone improved outcome compared with short-term detoxification, and extended medication-assisted therapy may be more helpful for young individuals with opioid dependence.
Journal ArticleDOI
Implementation of buprenorphine in the Veterans Health Administration: results of the first 3 years.
Adam J. Gordon,Jodie A. Trafton,Andrew J. Saxon,Allen L. Gifford,Francine Goodman,Vincent S Calabrese,Laura McNicholas,Joseph Liberto +7 more
TL;DR: VHA increased, but not uniformly, the non-formulary use of office-based buprenorphine during the first 3 years of availability.
Journal ArticleDOI
Sublingual buprenorphine/naloxone for chronic pain in at-risk patients: Development and pilot test of a clinical protocol
Andrew Rosenblum,Ricardo A. Cruciani,Eric C. Strain,Charles M. Cleland,Charles M. Cleland,Herman Joseph,Stephen Magura,Lisa A. Marsch,Laura McNicholas,Seddon R. Savage,Arun Sundaram,Russell K. Portenoy +11 more
TL;DR: A clinical protocol for safe transitioning to sublingual buprenorphine/naloxone for pain only when baseline opioid doses are within bounds that reduce AEs at transition and incorporates dose flexibility to further reduce risks is developed.